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DENGUE CON SIGNOS DE ALARMA Y LEPTOSPIROSIS EN UN PACIENTE PEDIÁTRICO CON COVID-19
Mayron D. Nakandakari1,a, Hamilton Marín-Macedo2,b, Raúl Seminario-Vilca2,b

CLINICAL CASE
CASE

ABSTRACT
Dengue and Leptospirosis are endemic metaxenic diseases that affect tropical and subtropical areas,
mostly in underdeveloped countries. In addition to this, the COVID-19 pandemic is causing a great deal
of damage to both the population and the health level. This is the case of a 13-year-old patient who had
fever, gingival and intermenstrual bleeding, abdominal pain and shortness of breath. She had SARSCoV-2 Inmunoglobulin M (IgM) and Inmunoglobulin G (IgG) positive rapid test, and positive serology
NS1 for Dengue and IgM for Leptospira. In addition, non-contrast pulmonary tomography showed
areas of consolidated and frosted glass at the base level, as well as cysturitis. Diagnoses of COVID-19
pneumonia, Dengue with warning signs and Leptospirosis were had. Therapeutics were based on fluid
therapy according to diuresis and blood pressure, symptomatic, oxygen support, constant monitoring
and antibiotic therapy with Ceftriaxone, having a favorable evolution.
Key words: Dengue; Leptospirosis; Coronavirus; Pediatrics (source: MeSH NLM).

RESUMEN
El Dengue y la Leptospirosis son enfermedades metaxénicas endémicas que afectan áreas tropicales y
subtropicales, en su mayoría de los países subdesarrollados. Sumado a ello la pandemia por la COVID-19,
estos vienen generando mucho daño tanto a la población como a nivel sanitario. Se presenta el caso
de una paciente de 13 años que cursó con fiebre, sangrado gingival e intermenstrual, dolor abdominal
y dificultad respiratoria. Tuvo prueba rápida SARS-CoV-2 Inmunoglobulina M (IgM) e Inmunoglobulina
G (IgG) positivo, y serología positiva NS1 para Dengue e IgM para Leptospira. Además, en la Tomografía
Pulmonar sin contraste se evidenciaron áreas de consolidados y de vidrio esmerilado a nivel de las bases,
además de cisuritis. Se tuvieron los diagnósticos de Neumonía COVID-19, Dengue con signos de alarma
y Leptospirosis. La terapéutica se basó en fluidoterapia según la diuresis y presión arterial, sintomáticos,
soporte oxigenatorio, monitoreo constante y antibioticoterapia con Ceftriaxona, teniendo evolución
favorable.
Palabras clave: Dengue; Leptospirosis; Infecciones por Coronavirus; Pediatría (fuente: DeCS BIREME).
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INTRODUCTION
Dengue and leptospirosis are prevalent metaxenic
diseases worldwide.
According to the World Health Organization (WHO),
dengue is responsible for around 390 million
infections per year, while leptospirosis is responsible
for an estimated 500 thousand cases per year(1,2).
Both diseases usually occur in tropical and subtropical
areas. It is much more frequent in underdeveloped
countries, where there is a fragmented health system
with many limitations(3).

The arrival of SARS-CoV-2 in the Amazonian regions
was inevitable, especially in Loreto - Peru, one of
the regions worst struck by COVID-19, with a casefatality rate of 4.38%, and where the Ministry of
Health reported only about 1000 deaths, a number
that is questionable and negligible due to the large
degree of underreporting.
COVID-19, added to dengue and leptospirosis, has
been causing great harm to the population and
health care(5).
Thus, we present a case of coexistence of infections
among COVID-19, dengue and leptospirosis in a
pediatric patient treated in a hospital in the Peruvian
Amazon.

CLINICAL CASE
This is the case of a 13-year-old patient from Iquitos
– Loreto.
Who five days before admission started having
recurrent fever and general malaise. Every time she
had a fever, her mother was giving her Paracetamol
500 mg.
Three days prior to admission, the patient noted
abundant active bleeding at the gingival level, as
well as low intermenstrual bleeding. She denied any
significant prenatal, natal, and postnatal history.
Due to the bleeding that she presented, she first
went to the Centro de Salud de Nanay, later being
referred to the Hospital de Apoyo Iquitos (HAI).
In that hospital, a hemogram was performed showing
https://inicib.urp.edu.pe/rfmh/vol21/iss2/24
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Likewise, she was referred to the Regional Hospital of
Loreto “Felipe Santiago Arriola Iglesias” (HRL), which
had been designated by the Ministry of Health as a
COVID-19 hospital.
At the time of admission to the HRL, her oxygen
saturation was 98% with HFNC at 2 liters/minute,
the respiratory rate was 20 breaths/minute, and she
maintained a mean arterial pressure (MAP) of 73.3
mmHg. On physical examination, she presented
a generalized skin rash, as well as features of an
old bleeding from the oral cavity. Regarding the
respiratory system, the vesicular murmur was
decreased in the lower 2/3 of both hemithoraxes.
There were no added sounds. Abdominally, there was
pain as a result of the superficial and deep palpation
in the epigastrium. No alterations were found in the
rest of the apparatus and systems.

CLINICAL CASE

In China, in December 2019, the report of cases of
infections by an unknown virus, currently called
SARS-CoV-2 and its disease COVID-19, began. This
virus has spread exponentially fast, affecting more
than 180 countries, becoming an uncontrollable
pandemic for all health systems(4).

leukopenia, neutropenia, lymphocytosis, and severe
thrombocytopenia, whereby she was hospitalized
for two days with a diagnoses of dengue with alarm
signs, in order to rule out leptospirosis. She started
fluid therapy with 0.9% sodium chloride at a rate of
3 cc/kg-hour. On the second day of hospitalization,
the patient began with respiratory distress. A rapid
test for COVID-19 was performed, obtaining a SARSCoV-2 IgM and IgG positive result, after which the
diagnosis of COVID-19 pneumonia was raised,
and intravenous ceftriaxone 1 g every 12 hours,
intravenous dexamethasone 4 mg at 8 am and 4
pm, and oxygen therapy by high-flow nasal cannula
(HFNC) at 2 liters/minute were started.

Compared with the hemogram performed in the
HAI, the complementary tests show a greater
decrease in leukocytes and hemoconcentration, as
well as an increase in platelets. There was also an
elevated quantitative C-reactive protein, and liver
enzymes (Aspartate aminotransferase and Alanine
aminotransferase) that were present at around 10
times their normal value. Likewise, the serology
result for dengue and leptospirosis was obtained,
with NS1 positive for dengue and IgM for Leptospira
(Table 1).
Radiologically, she had an anteroposterior chest X-ray
exam showing a bilateral interstitial pattern (Figure
1). In the Pulmonary Multi-slice spiral computed
tomography (MSCT) without contrast, areas of
consolidation and ground glass were observed at
the base level, in addition to cisuritis (Figure 2).
The diagnoses of the following diseases were raised:
1. COVID-19 pneumonia, 2. Dengue with warning
signs, 3. Leptospirosis.
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Within the therapeutics, fluid therapy was started
at 5 cc/ kg/hour and it was regulated according to
MAP and diuresis, ceftriaxone was increased to 80
mg/kg/day and oxygen support was progressively
withdrawn.

CLINICAL CASE

On day 5 of hospitalization in the HRL, platelets
increased, hemoconcentration did not return, fever

peaks subsided, and abdominal pain and respiratory
distress did not recur. Likewise, a predominance of the
upper and lower extremities skin rash was evidenced
type "white islands in a sea of red" characteristic of
the dengue convalescence phase (Figure 3). Due
to her evolution and favorable prognosis, she was
discharged from the hospital.

Figure 1. Anteroposterior chest X-ray on admission: bilateral interstitial infiltrate and horizontal cisuritis in
the right pulmonary field.

A

B

C

Figure 2. Pulmonary Multi-slice spiral computed tomography (MSCT) without contrast on admission: areas
of consolidation and ground glass at the base level, in addition to cisuritis in both lung fields.
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CLINICAL CASE

Figure 3. Skin rash on lower limbs type "white islands in a sea of red" from the convalescent phase of
dengue.

https://inicib.urp.edu.pe/rfmh/vol21/iss2/24
DOI: https://doi.org/10.25176/RFMH.v21i2.3459

Pág. 441

4

Nakandakari Gomez et al.: Dengue with signs of alarm and Leptospirosis in a pediatric patie
Nakandakari M et al

Rev. Fac. Med. Hum. 2021;21(2):438-444.

Table 1. Clinical laboratory results.
Reference
range (*)

Before
admission

5.5 - 15.5

Granulocytes (%)
Lymphocytes (%)

Laboratory tests

During hospitalization
Day 1

Day 2

Day 3

5.1

4.3

5.9

5.5

40 - 60

25.4

62.1

45.3

31.2

20 - 40

50.4

28.8

42

57.4

Eosinophils (%)

1-4

3.5

5

4.1

4.5

Monocytes (%)

2-8

1

0

2

1

≥ 12.5

14.3

14

13.7

13

37

41.9

41.9

39.8

38.9

150 - 350

17

45

48

81

Urea (mg/dL)

22 - 55

-

19

-

-

Creatinine (mg/dL)

0.5 - 1

-

0.9

-

-

240 - 479

-

468

-

-

<5

-

12.5

-

-

Aspartate aminotransferase (U/L)

15 - 40

-

728

-

-

Glutamate Aminotransferase (U/L)

10 - 35

-

215

-

-

Total protein (g/dL)

6,4 - 8

-

6.7

-

-

3.7 - 5.5

-

3.7

-

-

Total bilirubin (mg/dL)

0-1

-

0.8

-

-

Direct bilirubin (mg/dL)

0 - 0.3

-

0.7

-

-

-

-

O "Positive"

-

-

Blood culture

-

-

-

-

Negative

Urine culture

-

-

-

-

Negative

IgM:

-

Negative

-

-

-

NS1:

-

Positive

-

-

-

-

Reactive

-

-

-

SARS-CoV-2 IgM

-

Positive

-

-

-

SARS-CoV-2 IgG

-

Positive

-

-

-

Thick drop

-

-

Negative

-

-

Hemogram
Leukocytes (103/uL)

Hemoglobin (g/dL)

CLINICAL CASE

Hematocrit (%)
Platelets (103/uL)
Biochemical profile

Lactate Dehydrogenase (U/L)
C-Reactive Protein (mg/L)

Albumin (g/dL)

Blood type and RH factor
Cultures

ELISA for dengue

ELISA for Leptospira
IgM:
Rapid test COVID-19

(*) Reference range in pediatrics
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DISCUSSION
The case of a patient who began with episodes of
fever associated with gingival and vaginal bleeding
was reported, whose first diagnostic suspicion in
the Amazon region is metaxenic diseases, including
dengue.
In addition, it is very common to see cases of coinfection between dengue with leptospirosis,
Malaria and Urinary tract infections (UTIs), for this
reason it was sought to rule out these diseases(6,7).

On the other hand, it is mentioned that the pediatric
population is usually the least affected by COVID-19,
however, until epidemiological week 44 of 2020,
167 deaths were registered among children and
teenagers in Peru(8). Likewise, there were several
deaths of pediatric patients in the Loreto region who
presented severe symptoms of respiratory failure
associated with COVID-19.
Although the patient in the case did not die, she
presented the need for oxygen support due to
extensive lung lesions compatible with COVID-19.
Likewise, there was no need to use corticosteroids,
azithromycin, hydroxychloroquine or ivermectin,
drugs that had been suggested at that time for the
treatment of COVID-19(9).
Therapeutics consisted of adequate fluid therapy
management according to diuresis and blood
pressure, symptoms, oxygen support, constant
monitoring, and antibiotic therapy with Ceftriaxone
at 80 mg/kg/day due to the diagnosis of
leptospirosis(10,11).
Additionally, although in the reported case COVID-19
and dengue have been presented as co-infections,
it is important to emphasize that both share
similarities within the pathophysiological events, as
well as clinical findings such as maculopapular rash,
gastrointestinal and respiratory symptoms, among
others, which could be confusing to establish the
diagnosis of one or the other(12). Likewise, cases
where SARS-CoV-2 infection has led to false positives
in dengue screening have been reported(13).
Furthermore, both dengue and COVID-19 can cause

https://inicib.urp.edu.pe/rfmh/vol21/iss2/24
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On the flip side, one of the diagnostic challenges was
to determine the cause of the patient's shortness of
breath. At first, pleural effusion was suspected due
to a possible volume overload during hydration
therapy associated with capillary leakage in dengue
cases. Nonetheless, it was determined with the
help of a pulmonary MSCT that the respiratory
symptomatology was more associated with the
COVID-19 that the patient had developed.
It is essential to mention that the case was registered
during epidemiological week No. 26 of 2020. Despite
the fact that the Centro Nacional de Epidemiología,
Prevención y Control de Enfermedades (National
Center of Epidemiology, Prevention a Disease
Control, CDC) registered a lower number of dengue
cases around this epidemiological week, it should
be emphasized that the city of Iquitos and the
Department of Loreto as such are endemic areas of
dengue with frequent increases in the number of
cases, which constantly lead to the over-demand of
patients hospitalized for this disease.

CLINICAL CASE

Currently, although there are no official reports
that describe the rate of patients with COVID-19 coinfected with dengue and leptospirosis, this is very
frequently observed within hospital management in
the Loreto region.

hyperactivity of the immune system, which can lead
to events such as hypovolemic shock, vasoplegia,
and cardiopulmonary collapse. The immune
response can be so resounding that it can even
trigger a cytokine storm syndrome, complicating the
health and prognosis of the patient(14).

Among the limitations of the case, it was not possible
to take the molecular test for COVID-19 because
there was not material to carry out this test in the
hospital.

CONCLUSION
In conclusion, one of the pediatric cases showing
coinfection between the new COVID-19 and the
old and endemic metaxenics such as dengue and
leptospirosis was presented.
It is suggested that, despite the restrictions
established by the COVID-19 pandemic, it is necessary
to continue actively carrying out epidemiological
surveillance, as well as sanitary interventions for
the control of dengue and leptospirosis, such as
fumigation and the management of sewage. Due
to the social isolation and quarantine measures
dictated by the Peruvian Government, these
interventions were not carried out, leading to an
increase in dengue cases in the different regions of
the Peruvian Amazon.
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